In November 2019, I was delighted to receive the opportunity to attend the British Society for Heart Failure Annual General Meeting, kindly supported by the Emily Taylor Travel Grant from the Scottish Cardiac Society. The society’s flagship event, held in the Queen Elizabeth II Conference Centre, brings together health care professionals with an interest in heart failure from across the United Kingdom and further afield to learn about new developments in managing this complex syndrome.
This was the first occasion I was able to attend this prestigious meeting. I found the event extremely well organised with an interesting and varied programme. I was particularly struck at the high attendance with the main auditorium full with standing room only for the majority of the sessions.
The presenters covered a wide range of topics, from presenting the heart failure audit data to covering the fascinating topic of advanced heart failure, transplantation, and mechanical circulatory support (MCS). This session was of particular interest to me having completed a fellowship post with the Scottish National Advanced Heart Failure Service from 2018-2019. I enjoyed hearing presenters from different transplant centres talk about their services and hear their transplant/MCS success stories, which are always incredibly fulfilling to hear in a field where unfortunately many patients do not survive.
The enthusiasm of the delegates was obvious throughout, and it was particularly enjoyable to engage with likeminded colleagues during the refreshment breaks. I also relished the opportunity to catch up with former colleagues and hear about their projects and career plans.
The multidisciplinary nature of the meeting was clear and brought with it a very refreshing perspective. The value of specialist nurses and pharmacists is clear in heart failure in order to ensure we provide holistic and balanced evidence-based care to all our patients, and it was great to see the society promote this so well.
Overall, I am sure my attendance at the BSH will allow me to provide better care to patients I see everyday who suffer from heart failure. I was able to further establish links with members of the heart failure community not only in Scotland but the rest of the UK, and would thoroughly look forward to attending this excellent meeting again.
I am extremely grateful to the Scottish Cardiac Society for their support in allowing me to attend this meeting. With a limited study budget, it would have been much more difficult to attend without the kind support of the society.
I am grateful to the Scottish Cardiac Society for an award from the Emily Taylor Travel Fund which facilitated my attendance at the international cardiology conference ‘Transcatheter Cardiovascular Therapeutics 2019’ held recently in San Francisco, USA, from 25th – 29th September. At a moderated oral poster session I presented the findings of a clinical research project performed the Golden Jubilee National Hospital in Glasgow entitled “A Comparison of Clinical and Coronary Physiology Characteristics in Patients With and Without Type 4a Myocardial Infarction Following High-Speed Rotational Atherectomy-Assisted Percutaneous Coronary Intervention”.
As the authors of an oral presentation, my colleagues and I were also fortunate to have the written abstract simultaneously published in a special supplement of the Journal of the American College of Cardiology (JACC).
The presentation prompted some stimulating discussion from attendees at the session and facilitated the development of new contacts with similarly occupied researchers from around the world. This will hopefully lead to some future collaborations with our group in Glasgow.
I was able to attend numerous seminars highlighting exciting new research directions and debating current controversies in the field of invasive coronary physiology assessment.
The opportunity to discuss the minutiae of my subspecialty research interest in person with some of the world-renowned experts on faculty at these scientific sessions was invaluable to my continued learning and development as a clinical researcher.
Without the Society’s support, the cost of attending a scientific conference in the USA would have been prohibitive so I greatly appreciate both the educational experience and the opportunity to showcase our research to an international audience that this award provided.
Transcatheter Cardiovascular Therapeutics (TCT) is the largest international conference for interventional cardiology, with didactic sessions, case reviews, meet the experts and late breaking clinical trial sessions spread over five days. It serves as a platform for the latest evidence-based data on cardiovascular intervention to be shared with thousands of clinicians and scientists, and for practical education through the application of current and emerging technologies.
As an abstract presenter, I was provided with the opportunity to improve my presentation skills and disseminate my research. Engaging with the audience and answering their questions allowed me to learn through critical appraisal and feedback. The themed sessions also meant that I was able to benefit from presentations of similar focus and formulate further research questions.
Attending the numerous sessions at the conference has expanded my knowledge, not only in my area of interest, but also the broader field of interventional cardiology, which has proven useful in providing context for my own work. This is further emphasised by interactions with peers and senior academics working in the same area. Their insights and expert opinions have been invaluable.
Hands-on training sessions of various themes were also available. I had the opportunity to attend a session on large-bore access which was highly educational. The session concentrated on the use of ultrasound to guide puncture, different access points, and closure devices.
TCT 2019 has been a great experience. I have developed experience and skills by presenting my research before a group of experts in the field, and gained knowledge on the most up-to-date clinical practice and cardiovascular research that is taking place around the world.
Prize money from the Scottish Cardiac Society enabled me to attend The Royal College of Nursing International Research Conference 2019. I submitted two abstracts one of which was accepted as a poster presentation and one as an oral presentation. This three day conference provided an excellent platform for me to present my research on the use of qualitative research methods within the setting of a clinical trial.
Having the opportunity to speak at international conferences is undoubtedly excellent and necessary research training if a research career is to be pursued. The high cost associated with conference attendance means this can only be made possible through travel bursaries.
This conference provided me the opportunity to network with peers and colleagues from across the world. I was also able to showcase the support provided to nurses by both the University of Edinburgh Centre of Cardiovascular Science and the Scottish Cardiac Society by my attendance there. As well as leading discussions about my research topic I was also able to take part in fringe events regarding the career pathways for clinical academic nurses.
Without the support of the Emily Taylor Grant I would not have been able to attend this meeting. I am very grateful for the continuing support that the Scottish Cardiac Society offers to nurse researchers.
I am very grateful to the Scottish Cardiac Society for awarding me the Emily Taylor travel grant.
This has allowed me to attend ESC Congress 2019 in Paris France.
The European Society of Cardiology Congress is one of the most prestigious meetings in Cardiology where experts from all around the world gather to share their latest research.
For the last three years I have been reading for a PhD and running a small study looking at the importance of intramyocellular lipids in a population of type 2 diabetes patients and in fit athletes. Thanks to the Scottish Cardiac Society Emily Taylor grant I was able to attend this conference and present my research here. I’ve also had the opportunity to meet with other researchers from around the world and network.
During the congress I had the opportunity attend many clinical lectures and hands-on sessions which allowed me to be up to date with the latest clinical trials in Cardiology, improve my overall knowledge and skills. I am confident that this will translate into better patient care and I want to thank the Scottish Cardiac society once more for making this visit possible.
I am extremely grateful to the Scottish Cardiac Society for supporting me to attend The Midlands Echocardiography Foundation course. This 3-day course is an excellent introduction to the skill of echocardiography and has greatly helped me prepare for my upcoming fellowship post in cardiology.
Echocardiography is an essential skill to have as a cardiologist. This course offers an in-depth experience covering all aspects of echocardiography with practical sessions to gain experience in echo. Without this course, I would not be able to have dedicated such an intense amount of time to echocardiography which would have made it harder to understand the basic principles of echocardiography. Now having attended this course I am comfortable in using echo and I am able to obtain images of the 4 cardiac windows and make assessments such as LV function which will be crucial in my next post as cardiology clinical fellow.
The skills I have learned over these 3 days will serve me for the rest of my career and I am extremely grateful to the Scottish Cardiac Society and the Emily Taylor Travel Fund to give me the opportunity to attend this course.
I am very grateful to the Scottish Cardiac Society for supporting my travel via an Emily Taylor grant to attend and present my research at the European Society of Hypertension Annual Scientific meeting in Milan 2019. I gave an oral presentation and discussed the results of our clinical trial that investigated the use of allopurinol versus placebo to subjects with hypertensive heart disease. This was a unique opportunity at an international meeting to both further the knowledge in hypertension and promote Scottish research to a global audience. I laud the SCS for supporting trainees to attend meeting and courses, which we may otherwise not be able to go to.
I am profoundly grateful to SCS for supporting my travel to
EuroPCR 2019, which enabled me to present two very interesting
cases at the conference.
EuroPCR is the official annual meeting of the European
Association of Percutaneous Cardiovascular Interventions (EAPCI)
and the world-leading Course in Interventional Cardiovascular
EuroPCR was celebrating its 30th anniversary this year and it was
attended by more than 11000 active participants and around 4700
I was able to present my a couple of cases during the conference.
This could not have been possible without the support from SCS.
I was able to share my experience with colleagues from all across
the world and the live sessions during the conference were a great
resource to observe international practice in interventional
cardiology and interact with the panel of interventionists and
The Emily Taylor grant helped me to attend the conference, share
knowledge and experience with professionals from around the
world and learn new skills in interventional cardiology. I am hopeful
that my knowledge and skills will be used for improvement of many
lives of patients with cardiac problems in general and ischemic
heart disease in particular.
As Interventional sub-specialist trainee, I am wholeheartedly pleased to share my thankful and great gratitude for the Scottish Cardiac Society via Emily Taylor travel fund. Which had made my oral presentation for an interesting unique interventional case from North of Scotland to be possible to be shared at international level in the most prestigious European intervention conference across Europe EuroPCR in Paris 05/2019 particularly this year which was quite buzzy year since it was celebrating it is 30th Anniversary. I have to say our case has been well received in the session which was combined with the Portuguese Cardiac society. Following the meeting and in this regard, I have received special warm thanks in form of a certificate of appreciation from the president of the Scottish Cardiac Society Prof.H. Eteiba to congratulate me on my excellent presentation and contribution to the Scottish cardiac society program since my case has been selected among only 2 cases from whole Scotland via the Scottish Cardiac Society to be presented at Euro PCR this year which of course this was of great value endeavouring my career as Interventional Fellow.
Beside my oral presentation, Indeed with no doubt it was fantastic platform for me to learn a lot from leading experts in their fields new technologies, trials and techniques having attended blends of Interesting complex intervention sessions which of course enriched my knowledge greatly leading to reflect this across the department and my colleagues fellows. In addition to all above I had the chance to attend the European Fellow Interventional course which was exceptionally good in providing comprehensive overall refreshment about the whole areas of Intervention. Moreover, I have the chance to meet with my Co-Fellows from other centers through the hands on sessions.
Lastly,I am extremely grateful to have been granted the fund. It has enabled attendance at highly educational meetings which would have been otherwise impossible.
I am extremely grateful to the Scottish Cardiac Society for supporting my travel to EuroCMR 2019 in Venice. As a final year trainee in cardiac imaging and having just completed my CMR research at Barts Heart Centre London, I am keen to continue to develop further my clinical and research interest and keep up-to-date on the latest development in CMR by attending the conference. I found the sessions including the clinical cases sessions extremely educational and useful for my clinical practice.
I also had the opportunity to present a case series from Glasgow on the clinical utility of multiparametric CMR in the assessment of cardiac involvement in Becker muscular dystrophy where a combination of CMR and cardiac biomarkers could potentially be used for monitoring and guiding therapy particularly in patients with normal left ventricular ejection fraction.
This conference has also provided me the platform to network with peers and colleagues from across the world. I am very grateful for the support from the Emily Taylor Travel Fund in enabling me to attend this valuable meeting.